Home Compare BAYN.DE vs HOLX
Stock Comparison · Structural lead, mixed market

Bayer Aktiengesellschaft vs Hologic: Which Stock Looks Stronger in 2026?

Hologic holds the cleaner structural position, with the lead spread across stability and profitability. Bayer Aktiengesellschaft still has the edge on valuation, which keeps the comparison from looking entirely one-sided. The market setup is mixed, without a decisive signal in either direction. The market is not adding a decisive signal either way — the structural read carries the weight.

The comparison is based on similar long-term financial trajectories, not sector labels.

Updated 2026-04-05

This is not just a one-metric split: both stability and profitability materially support the lead. Hologic, Inc. leads by 31 points on the overall comparison score.

Trajectory Similarity
0.66
Moderately similar
Peer-set rank: #21
within Bayer Aktiengesellschaft's functional peer set

These two companies are linked by measured long-term financial trajectory similarity within the selected peer universe.

A moderate similarity means the pair is structurally comparable, but not a near-twin trajectory match.

The clearest structural overlap shows up in revenue growth trajectory and margin trend.

Similarity drivers
revenue growth trajectorymargin trend
How to read the score
0.85–1.00 · Very similar0.70–0.84 · Similar0.55–0.69 · Moderately similarbelow 0.55 · Loose match
Peer-Relative Score
BAYN.DE
Bayer Aktiengesellschaft
39
Peer-Score
Signal qualityHigh
vs
HOLX
Hologic, Inc.
70
Peer-Score
Signal qualityHigh

Scores reflect position relative to comparable companies with similar long-term financial trajectories.

The largest gaps do not all point in the same direction.

Dimension spread: BAYN.DE vs HOLX Profitability 16 75 Stability 28 90 Valuation 88 67 Growth 11 46 BAYN.DE HOLX
Gap Ranking
#1 Stability +62
#2 Profitability +59
#3 Growth +35
#4 Valuation +21
Price Setup

Left means cheaper relative valuation. Higher means stronger structure.

Price setup map for BAYN.DE and HOLX Stronger + cheaper Stronger + richer Weaker + cheaper Weaker + richer BAYN.DEHOLX Relative valuation Structural strength

Hologic, Inc. is cheaper, but Bayer Aktiengesellschaft is still stronger.

Valuation position uses Forward P/E and peer-relative PE percentile (idx_pct_pe) where available.

Relative Position vs Comparable Companies
Stability
On stability, Hologic, Inc. ranks near the top of the group; Bayer Aktiengesellschaft sits in the weaker half.
Profitability
The same broad pattern appears on profitability: Hologic, Inc. ranks near the top of the group, while Bayer Aktiengesellschaft stays in the weaker half.
Stability — Dominant Gap
BAYN.DE
28
HOLX
90
Gap+62in favour of HOLX

The clearest distance comes from a steadier profile over time.

What keeps the gap from being one-sided

Absolute pricing still looks more supportive for Bayer Aktiengesellschaft, with a forward P/E that is 7.2 turns lower there.

What this means for the comparison

The lead is built on both stability and profitability — though valuation still provides a counterweight.

Explore full peer positioning in AssetNext

Break down the BAYN.DE vs HOLX comparison across all dimensions with the full interactive tool.

Explore full breakdown →
Other comparisons with conflicting dimension signals

Explore how BAYN.DE and HOLX each compare against other companies in their peer groups.

Rule-based, descriptive analysis only. Derived from peer percentile dimensions. Not investment advice. Peer groups are determined algorithmically based on structural similarity — not by sector classification alone.

How AssetNext Peer Scores Work

AssetNext scores reflect each company's structural position within its functional peer group — not a ranking against all stocks simultaneously. Peers are identified by similarity across eight financial dimensions, including revenue growth trajectory, margin structure, capital intensity, and earnings stability. A score of 75 means the company ranks in the top quartile within its own peer group, not the entire market.

Four dimension scores drive the overall peer score: Growth (revenue trajectory and expansion dynamics), Quality (margin structure and capital efficiency), Valuation (peer-relative pricing on standard multiples), and Stability (earnings consistency and financial predictability). Each dimension is scored 0–100 relative to the peer group, then combined into an overall peer score using equal weighting.

Scores are recalculated periodically as underlying financial data is updated. All analysis is descriptive and rule-based — AssetNext describes structural realities and never issues buy, sell or hold recommendations.